The head of drug and chemical giant Bayer AG's battered pharmaceutical business has been replaced by the chief of its U.S. drugs division, the company said Wednesday. The departure of David Ebsworth, ...

Just two months ago, shares in the German chemical giant Bayer fell sharply after the company withdrew a cholesterol-lowering drug from the market in the wake of 52 related deaths. Now those shares ...

A safety review of products used to treat high cholesterol is under way following pharmaceutical firm Bayer's withdrawal of the drug Lipobay, also known as Baycol. The European Medicines Evaluation ...

Doctors who prescribed cholesterol-fighting drug Lipobay to more than 25 of their patients were promised a free trip on the Orient Express train by drug company Bayer. Bayer used the aggressive ...

IndustryWeek champions the people and companies that make the U.S. manufacturing sector a global leader. We provide essential information for the decision-makers and disruptors driving manufacturing's ...

Bayer's third-quarter operating profit before exceptional costs dropped 90.7% to 66m euros ($58.20m), while sales fell 5.9% to 6.868bn euros. Bayer, Europe's second-largest chemicals group, put the ...

The British government warned the German pharmaceutical company, Bayer, in June 2001 that it needed to change the health warning labels for its anticholesterol drug Lipobay. This shows that the risks ...

NEW DELHI: This medicine has been linked to the death of 52 patients in the US and Europe, forcing the company to withdraw it from these markets. But it's freely available in India. new delhi: this ...

The cholesterol-lowering drug Lipobay (cerivastatin) was withdrawn last month by pharmaceutical giant Bayer. It has been linked with a number of deaths caused by a condition characterised by muscle ...

German drug giant Bayer is facing a fresh wave of litigation over its recalled anti-cholesterol drug Lipobay. The company's share price plunged after it said might not be able to cover the cost of ...

The cholesterol-lowering drug Lipobay (cerivastatin) was withdrawn last month by pharmaceutical giant Bayer. It has been linked with a number of deaths caused by a condition characterised by muscle ...